NCT01233505
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors treatment 1 terminated NCT02314156
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy prevention 2 completed NCT02208375
mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian treatment 1 / 2 active_not_recruiting NCT00892736
Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy treatment 1 completed NCT00673335
Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation prevention 3 completed NCT01540565
Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 completed NCT00664781
Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer treatment 2 completed NCT00897455
Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers No drug interventions Not Available Not Available unknown_status NCT01874184
Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer No drug interventions basic_science Not Available completed NCT00321633
Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer treatment 2 completed NCT00899145
Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers No drug interventions Not Available Not Available withdrawn NCT01097278
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer No drug interventions prevention Not Available completed NCT00080756
Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease prevention 2 active_not_recruiting NCT00098800
Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries prevention Not Available completed NCT01219075
Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer No drug interventions prevention Not Available completed NCT00084370
Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy prevention Not Available withdrawn NCT00986206
Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer No drug interventions Not Available Not Available completed NCT00535119
Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer treatment 1 completed NCT01154426
ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT01905046
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer prevention 3 active_not_recruiting